Table 1.
Baseline characteristics by treatment arm
| Key characteristics | LSVT | NHS SLT | Deferred |
|---|---|---|---|
| (n = 30) | (n = 30) | (n = 29) | |
| Demographic | |||
| Age, mean (SD) | 67 (8.4) | 68 (10.3) | 65 (7.5) |
| Gender: n (%) male | 23 (77) | 23 (77) | 23 (79) |
| Clinical history | |||
| Years since diagnosed, mean (SD) | 6.1 (3.7) | 5.6 (4.2) | 4.9 (3.9) |
| Severity (H&Y stage) 2.5 and above, n (%) | 10 (34) | 13 (44) | 6 (20) |
| Number of PD medications, mean | 2.1 (1) | 1.9 (1) | 1.6 (0.9) |
| Perception of speecha: n (%) | |||
| Patient perceives speech/voice problems | 23 (82) | 23 (79) | |
| Speech affects social activities | 18 (64) | 14 (48) | |
aCollected as part of initial SLT assessment, so only available for LSVT and NHS SLT groups